Keyphrases
Israel
100%
Shigella
35%
Shigella Sonnei
29%
Shigellosis
28%
Israeli
21%
Older Adults
20%
Lipopolysaccharide
20%
Seroprevalence
18%
Vaccination
17%
Helicobacter Pylori (H. pylori)
16%
Confidence Interval
16%
Seroepidemiology
15%
Helicobacter Pylori Infection
15%
Shigella Flexneri
14%
Risk Factors
14%
IgG Antibody
13%
COVID-19
12%
Hospitalization
12%
Shigella Flexneri 2a
11%
Seropositivity
11%
Israeli Population
11%
Immunogenicity
11%
Israeli Arabs
10%
Diarrhea
10%
Antibody Level
10%
Epidemiology
10%
Enterotoxigenic Escherichia Coli
9%
Vaccinees
9%
Soldiers
9%
Rotavirus
8%
Immunization
8%
Age Groups
7%
Arab
7%
Young children
7%
Diarrheal Disease
7%
Rotavirus Gastroenteritis
7%
Revaccination
7%
Immunoglobulin
7%
Shigella Vaccine
7%
Arab children
6%
Immune Response
6%
Rotavirus Vaccine
6%
BNT162b2 Vaccine
6%
Acute Gastroenteritis
6%
Non-typhoidal Salmonella
6%
Conjugate Vaccine
6%
Enzyme-linked Immunosorbent Assay (ELISA)
6%
Vaccine Candidate
5%
Stool
5%
Socioeconomic Status
5%
Immunology and Microbiology
Vaccine Efficacy
28%
Monospecific Antibody
27%
Vaccination Policy
22%
Shigella
22%
Prevalence
21%
Helicobacter Pylori
18%
Seroprevalence
18%
Immunoglobulin G Antibody
18%
Seropositivity
13%
Pylorus
12%
Shigella sonnei
12%
ELISA
11%
Infectious Agent
10%
Salmonella
9%
Enterotoxigenic Escherichia Coli
8%
Gastroenteritis
8%
Immunoglobulin A
7%
Serotype
7%
COVID-19
7%
Shigella flexneri
6%
Polymerase Chain Reaction
6%
Rotavirus
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Hepatitis A Virus
5%
Peptoclostridium difficile
5%
Varicella Zoster Virus
5%
Vibrio vulnificus
5%
Infectious Disease
5%
Immunoglobulin A Antibody
5%
Enzyme-Linked Immunosorbent Assay
5%
Immune Response
5%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
36%
Shigella
28%
Disease
23%
Shigellosis
22%
Lipopolysaccharide
17%
Shigella sonnei
15%
Diarrhea
14%
Vaccination Policy
14%
Shigella flexneri
13%
Gastroenteritis
12%
Helicobacter Infection
10%
Immunogenicity
10%
Rotavirus
10%
Prevalence
8%
Immunoglobulin G Antibody
8%
Enterotoxigenic Escherichia Coli
8%
Helicobacter Pylori
8%
Salmonella
7%
SARS Coronavirus
7%
Conjugate Vaccine
7%
Immunoglobulin A
7%
Shigella Vaccine
6%
Enzyme-Linked Immunosorbent Assay
6%
Seroprevalence
6%
Acute Gastroenteritis
5%
Norovirus
5%
Infectious Agent
5%